⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABSI News
Absci Corporation Common Stock
Amylin Analogs and Combination Therapies Clinical Trial Landscape Expands as 15+ Leading Companies Accelerate Drug Development | DelveInsight
globenewswire.com
AZN
LLY
NVO
PFE
AMGN
BMY
JNJ
REGN
VKTX
ZETA
CRSP
IONS
AXSM
MRK
GSK
SNY
IMUX
BMEA
ALKS
ALT
AARD
NOV
CARM
CRIS
LPCN
GILD
REG
SPRO
ABSI
ALZN
ANVS
BV
ARCL
ACIU
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
prnewswire.com
AMD
HYFT
RXRX
ABSI
TEM
NVDA
As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22
prnewswire.com
ABCL
VKTX
HYFT
ABSI
NVDA
Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026
globenewswire.com
ABSI
As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models
prnewswire.com
AZN
HYFT
ABSI
NVDA
CERT
The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel
prnewswire.com
GOOGL
IONQ
AZN
ARQQ
QBTS
ABSI
NVDA
IBM
RGTI
CERT
Form 8-K
sec.gov
ABSI
Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
globenewswire.com
ABSI
Form 8-K
sec.gov
ABSI
Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)
globenewswire.com
ABSI